|
ZNF563 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.00219999999729E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77480000000241E-05 |
| Normal-vs-Stage2 |
1.313590E-01 |
| Normal-vs-Stage3 |
1.76912999999557E-05 |
| Normal-vs-Stage4 |
9.041500E-04 |
| Stage1-vs-Stage2 |
1.873550E-01 |
| Stage1-vs-Stage3 |
3.792400E-01 |
| Stage1-vs-Stage4 |
6.961400E-01 |
| Stage2-vs-Stage3 |
8.546000E-02 |
| Stage2-vs-Stage4 |
1.695020E-01 |
| Stage3-vs-Stage4 |
8.069200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21179999999999E-05 |
| Normal-vs-AfricanAmerican |
3.776200E-03 |
| Normal-vs-Asian |
5.211000E-04 |
| Caucasian-vs-AfricanAmerican |
7.386000E-01 |
| Caucasian-vs-Asian |
7.714600E-01 |
| AfricanAmerican-vs-Asian |
8.747400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.803550E-03 |
| Normal-vs-Female |
1.86001999999963E-05 |
| Male-vs-Female |
6.859800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.392600E-04 |
| Normal-vs-Age(41-60Yrs) |
9.64999999999439E-05 |
| Normal-vs-Age(61-80Yrs) |
2.315600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.414260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.588800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.598800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.811200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.789000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.397000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.109000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.372300E-02 |
| Classical-VS-Follicular |
6.654000E-01 |
| Classical-VS-Other |
6.176800E-01 |
| Classical-VS-Normal |
3.210300E-04 |
| Tall-VS-Follicular |
2.549200E-01 |
| Tall-VS-Other |
4.489000E-01 |
| Tall-VS-Normal |
2.210900E-04 |
| Follicular-VS-Other |
5.437600E-01 |
| Follicular-VS-Normal |
7.638500E-04 |
| Other-VS-Normal |
3.777000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.385100E-04 |
| Normal-vs-N1 |
2.12729999999883E-05 |
| N0-vs-N1 |
1.324020E-01 |
|
|
